Confluence Life Sciences is a drug discovery and development company founded by accomplished pharmaceutical experts and using cutting-edge and proprietary methods to discover and develop novel drugs - kinase inhibitors - focused on a key class of targets that have become critical in both human and animal health care.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/17/12 | $4,000,000 | Series A |
BioGenerator DFJ Mercury Missouri Technology Corporation | undisclosed |
| 02/26/14 | undisclosed |
Epidarex Capital | undisclosed |
